Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 19891, 5 pages
http://dx.doi.org/10.1155/2007/19891
Research Article

Inflammatory Marker but Not Adipokine Predicts Mortality among Long-Term Hemodialysis Patients

1Division of Nephrology, Department of Internal Medicine, Chang-Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University, College of Medicine, Kaohsiung Hsien 833, Taiwan
2Department of Psychiatry, Chang-Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University, College of Medicine, Kaohsiung Hsien 833, Taiwan
3Department of International Trade, Cheng Shiu University, Kaohsiung Hsien 833, Taiwan

Received 24 July 2007; Revised 10 October 2007; Accepted 22 October 2007

Copyright © 2007 Yu-Che Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Clinical epidemiology of cardiovascular disease in chronic renal disease,” American Journal of Kidney Diseases, vol. 32, no. 5, suppl. 3, pp. 112–119, 1998. View at Google Scholar
  2. P. Stenvinkel, O. Heimbürger, B. Lindholm, G. A. Kaysen, and J. Bergström, “Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome),” Nephrology Dialysis Transplantation, vol. 15, no. 7, pp. 953–960, 2000. View at Google Scholar
  3. K. Kalantar-Zadeh, T. A. Ikizler, G. Block, M. M. Avram, and J. D. Kopple, “Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences,” American Journal of Kidney Diseases, vol. 42, no. 5, pp. 864–881, 2003. View at Google Scholar
  4. P. Stenvinke, P. Barany, S. H. Chung, B. Lindholm, and O. Heimbürger, “A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients,” Nephrology Dialysis Transplantation, vol. 17, no. 7, pp. 1266–1274, 2002. View at Google Scholar
  5. C. Zoccali, F. Mallamaci, and G. Tripepi, “Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease,” Nephrology Dialysis Transplantation, vol. 19, suppl. 5, pp. 67–72, 2004. View at Publisher · View at Google Scholar
  6. J. Y. Yeun, R. A. Levine, V. Mantadilok, and G. A. Kaysen, “C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients,” American Journal of Kidney Diseases, vol. 35, no. 3, pp. 469–476, 2000. View at Google Scholar
  7. K. Iseki, M. Tozawa, S. Yoshi, and K. Fukiyama, “Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients,” Nephrology Dialysis Transplantation, vol. 14, no. 8, pp. 1956–1960, 1999. View at Publisher · View at Google Scholar
  8. J. Axelsson, O. Heimbürger, B. Lindholm, and P. Stenvinkel, “Adipose tissue and its relation to inflammation: the role of adipokines,” Journal of Renal Nutrition, vol. 15, no. 1, pp. 131–136, 2005. View at Publisher · View at Google Scholar
  9. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, and C. Wanner, “Inflammation enhances cardiovascular risk and mortality in hemodialysis patients,” Kidney International, vol. 55, no. 2, pp. 648–658, 1999. View at Publisher · View at Google Scholar
  10. D. A. Goodkin, J. Bragg-Gresham, K. G. Koenig et al., “Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS),” Journal of the American Society of Nephrology, vol. 14, no. 12, pp. 3270–3277, 2003. View at Google Scholar
  11. C. Wanner and T. Metzger, “C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 17, suppl. 8, pp. 29–32, 2002. View at Google Scholar
  12. P. Stenvinkel and A. Alvestrand, “Inflammation in end-stage renal disease: sources, consequences, and therapy,” Seminars in Dialysis, vol. 15, no. 5, pp. 329–337, 2002. View at Publisher · View at Google Scholar
  13. R. Pecoits-Filho, P. Barany, B. Lindholm, O. Heimbürger, and P. Stenvinkel, “Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment,” Nephrology Dialysis Transplantation, vol. 17, no. 9, pp. 1684–1688, 2002. View at Google Scholar
  14. J. Bergstrom and B. Lindholm, “Malnutrition, cardiac disease, and mortality: an integrated point of view,” American Journal of Kidney Diseases, vol. 32, no. 5, pp. 834–841, 1998. View at Google Scholar
  15. P. Stenvinkel, O. Heimbürger, F. Paultre et al., “Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure,” Kidney International, vol. 55, no. 5, pp. 1899–1911, 1999. View at Publisher · View at Google Scholar
  16. B. R. Bistrian, “Interaction between nutrition and inflammation in end-stage renal disease,” Blood Purification, vol. 18, no. 4, pp. 333–336, 2000. View at Publisher · View at Google Scholar
  17. C. Zoccali, G. Tripepi, F. Cambareri et al., “Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients,” Journal of Renal Nutrition, vol. 15, no. 1, pp. 125–130, 2005. View at Publisher · View at Google Scholar
  18. C. Zoccali, F. Mallamaci, G. Tripepi et al., “Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 134–141, 2002. View at Google Scholar
  19. C. Zoccali, F. Mallamaci, and G. Tripepi, “Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease,” Kidney International, Supplement, vol. 63, no. 84, pp. 65–68, 2003. View at Google Scholar
  20. C.-T. Lee, C.-H. Lee, Y. Su et al., “The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients,” International Journal of Artificial Organs, vol. 27, no. 10, pp. 835–841, 2004. View at Google Scholar
  21. V. Menon, L. Li, X. Wang et al., “Adiponectin and mortality in patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2599–2606, 2006. View at Publisher · View at Google Scholar
  22. S. Pilz, H. Mangge, B. Wellnitz et al., “Adiponectin and mortality in patients undergoing coronary angiography,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4277–4286, 2006. View at Publisher · View at Google Scholar
  23. R. S. Lindsay, H. E. Resnick, J. Zhu et al., “Adiponectin and coronary heart disease: the strong heart study,” Arteriosclerosis, thrombosis, and vascular biology, vol. 25, no. 3, pp. e15–e16, 2005. View at Publisher · View at Google Scholar
  24. D. Rothenbacher, H. Brenner, W. März, and W. Koenig, “Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers,” European Heart Journal, vol. 26, no. 16, pp. 1640–1646, 2005. View at Publisher · View at Google Scholar